Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from Synnovation
Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from…
Immunology Today—March 18, 2026
This week’s Immunology update highlights regulatory progress, late-stage…
Neuroscience Today—March 4, 2026
This week's Neuroscience update covers key developments across late-stage…
Immunology Video Recap—February 25, 2026
This biweekly Immunology video recap highlights key developments across…
Immunology Today—February 25, 2026
This week's Immunology update summarizes covering clinical-trial readouts and…
Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide licensing agreement
Lucid Diligence Brief: Unnatural Products Novartis macrocyclic peptide…
Oncology Today—February 9, 2026
This week's Oncology update , covers regulatory actions, late-stage clinical…
Neuroscience Video Recap—February 4, 2026
This biweekly Neuroscience video recap covers key updates, including regulatory…
Neuroscience Today—February 4, 2026
This week's Neuroscience update summarizes key developments in clinical…
Immunology Video Recap—January 28, 2026
This biweekly Immunology video recap highlights key regulatory actions,…
Neuroscience Video Recap—January 21, 2026
This Neuroscience video recap highlights key developments across regulatory…
Immunology Today—January 21, 2026
This week's Immunology edition covers major regulatory milestones, late-stage…




